From Barchart:

Analysts are predicting significant growth for a biotech stock, with expectations for the share price to nearly triple over the next year. This news has caught the attention of Wall Street, as the biotech industry continues to be a point of interest for investors. The specific details and factors contributing to these growth projections are likely to be closely monitored in the coming months as the stock’s performance unfolds.



Read more: Wall Street Expects 190% Upside for This Biotech Stock